Shengyuan Pharmaceutical's 2025 Dealer Cooperation Negotiation Conference was successfully held, and new partners from three regions signed contracts successfully

Time :2025-06-17

On the afternoon of June 16th, the Shengyuan Pharmaceutical 2025 Dealer Cooperation Negotiation Conference (Second Session) with the theme of "Riding on the Trend and Working Together for Far Future" was held grandly. This conference once again attracts new partners from Shenzhen, Zhejiang, and Shandong to jointly explore market opportunities and complete strategic signings.



Shengyuan Environmental Protection Chairman Zhu Yuxiuan, Deputy General Managers Chen Wenyu and Lin Wenfeng, Executive Vice General Manager of the Marketing Department Zhang Chengxue, Deputy General Manager Zhu Zhuowei, Brand Director Shi Qiaochao, and others attended the event. They discussed the future of the taurine health industry with special guests Liu Shengshu, Executive Deputy Director of the District Elderly Education Commission and President of the District Elderly University (formerly a standing committee member of the Fengze District Committee), and Professor Wang Guoquan from Huaqiao University.



At the meeting, Brand Director Shi Qiaochao comprehensively interpreted the brand strategy of Shengyuan Pharmaceutical and the advantages of taurine series products. Vice General Manager of the Marketing Department Zhu Zhuowei elaborated on investment policies, market support plans, and cooperation models, and interacted with dealers to answer their concerns on site.

Chairman Zhu Yuxiuan attended the meeting and delivered an important speech. He pointed out that under the guidance of the national "Healthy China 2030" strategy, the big health industry is facing unprecedented development opportunities. In this context, taurine, which has unique effects such as antioxidant, fatigue relief, and immune enhancement, is gradually becoming an important ingredient in functional foods, specialty foods, and health foods. Shengyuan Pharmaceutical always adheres to the principle of focusing on product efficacy, driven by innovation, and will continue to optimize product structure, focusing on building a functional health product matrix with taurine as the core, and achieving resource sharing and complementary advantages with distributors. This collaboration with dynamic new partners from Shenzhen, Zhejiang, and Shandong will further enhance the brand's regional penetration, bring higher quality health products to consumers, and work together with partners to promote the development of the taurine health industry.



Representatives from distributors in Shenzhen, Zhejiang and other places shared their product usage experience and expressed firm confidence in the prospects of this cooperation and market expansion. They believe that with the continuous upgrading of health consumption demand, Shengyuan Pharmaceutical's taurine series products will occupy an important market share in the functional beverage and health food fields with their differentiated advantages.


  

Dealer representative speaks


Liu Shengshu, Executive Deputy Director of the District Elderly Education Commission and President of the District Elderly University (formerly a standing committee member of the Fengze District Committee), Professor Wang Guoquan from Huaqiao University, and other attending guests jointly discussed national policies, industry trends, and the research value of taurine. They highly praised Shengyuan Pharmaceutical's product concept and the development direction of the big health industry.


  
Vice Director Liu Shengshu delivered a speech

Professor Wang Guoquan's speech


Under the joint witness of all attending guests, Shengyuan Pharmaceutical signed cooperation agreements with new partners in Shenzhen, Zhejiang, and Shandong, officially establishing cooperative relationships. This marks a solid step forward for Shengyuan Pharmaceutical's channel layout in the national market and injects new development momentum.


    

Shenzhen, Zhejiang, and Shandong distributors signed contracts


Under the guidance of the national "Healthy China 2030" strategy, the big health industry is entering a golden period of development. Shengyuan Pharmaceutical will take strategic cooperation as a new starting point, continue to deeply cultivate the taurine health industry, integrate high-quality resources, strengthen channel construction, deepen industry university research cooperation, enhance product competitiveness and other measures, work together with distributor partners to promote the high-quality application of taurine in the health industry, help improve the national health level, and create a new ecology of healthy consumption.

Back